Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery
CHICANE
A Cohort Study to Assess the Effectiveness of Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery Patients in the COVID-19 Pandemic
1 other identifier
observational
150
1 country
1
Brief Summary
trial to assess the effectiveness of pre-operative screening for COVID-19 in patients undergoing elective cancer surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2020
CompletedStudy Start
First participant enrolled
June 25, 2020
CompletedFirst Posted
Study publicly available on registry
June 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2020
CompletedJuly 20, 2020
June 1, 2020
2 months
June 23, 2020
July 17, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
diagnosis of COVID before surgery
Diagnosis of COVID on day of surgery (based on Clinical symptoms +/- positive swab diagnosis)
prior to surgery
Secondary Outcomes (1)
diagnosis of COVID after surgery
14 days post op
Study Arms (1)
study patients
Patients undergoing elective cancer surgery, who will receive pre-operative screening including reporting symptoms and nose and throat swabbing 48 hours prior to surgery
Interventions
reported symptoms plus nose and throat swabbing 48 hrs prior to surgery
telephone consult 14 days (+/- 2 days) to assess for any COVID-19 symptoms
Eligibility Criteria
All adult patients undergoing elective cancer surgery with an inpatient stay
You may qualify if:
- participants capable of giving informed consent,
- gender: Male and Female
- Age: 18 years and above
- Preoperative cancer patients (elective)
- Willing to be contacted by phone after hospital discharge
- Patients listed for inpatient admission postoperatively (cancer patients)
You may not qualify if:
- Cancer patients who require non-cancer surgery
- emergency cancer operations
- Patients under the age of 18
- Patients who do not have capacity to consent
- Cancer patients not requiring an inpatient stay postoperatively
- Patients who it was not anticipated would require an inpatient stay preoperatively but required admission after surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Liverpool University Hospitals NHS Foundation Trust
Liverpool, Merseyside, L9 7AL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Jones, MBChB
Liverpool University Hospitals NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2020
First Posted
June 29, 2020
Study Start
June 25, 2020
Primary Completion
August 25, 2020
Study Completion
September 25, 2020
Last Updated
July 20, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
will not be shared